Besides, PLOD1 is also significantly overexpression in a wide range of malignancies, including esophageal squamous cell carcinoma, gastric cancer, and colorectal cancer, and is significantly associated with poor patient outcomes [21, 22]. This evidence concerns the gene PLOD1 and esophageal squamous cell carcinoma.